Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 11;11(5):973.
doi: 10.3390/vaccines11050973.

COVID-19 Vaccine Perceptions among Ebola-Affected Communities in North Kivu, Democratic Republic of the Congo, 2021

Affiliations

COVID-19 Vaccine Perceptions among Ebola-Affected Communities in North Kivu, Democratic Republic of the Congo, 2021

Stephanie Chow Garbern et al. Vaccines (Basel). .

Abstract

Populations affected by humanitarian crises and emerging infectious disease outbreaks may have unique concerns and experiences that influence their perceptions toward vaccines. In March 2021, we conducted a survey to examine the perceptions toward COVID-19 vaccines and identify the factors associated with vaccine intention among 631 community members (CMs) and 438 healthcare workers (HCWs) affected by the 2018-2020 Ebola Virus Disease outbreak in North Kivu, Democratic Republic of the Congo. A multivariable logistic regression was used to identify correlates of vaccine intention. Most HCWs (81.7%) and 53.6% of CMs felt at risk of contracting COVID-19; however, vaccine intention was low (27.6% CMs; 39.7% HCWs). In both groups, the perceived risk of contracting COVID-19, general vaccine confidence, and male sex were associated with the intention to get vaccinated, with security concerns preventing vaccine access being negatively associated. Among CMs, getting the Ebola vaccine was associated with the intention to get vaccinated (RR 1.43, 95% CI 1.05-1.94). Among HCWs, concerns about new vaccines' safety and side effects (OR 0.72, 95% CI 0.57-0.91), religion's influence on health decisions (OR 0.45, 95% CI 0.34-0.61), security concerns (OR 0.52, 95% CI 0.37-0.74), and governmental distrust (OR 0.50, 95% CI 0.35-0.70) were negatively associated with vaccine perceptions. Enhanced community engagement and communication that address this population's concerns could help improve vaccine perceptions and vaccination decisions. These findings could facilitate the success of vaccine campaigns in North Kivu and similar settings.

Keywords: Democratic Republic of the Congo; Ebola Virus Disease; SARS-CoV-2; humanitarian; outbreak; pandemic; vaccine acceptance; vaccine hesitancy; vaccines.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest. The findings and conclusions in this paper are those of the authors and do not necessarily represent the official position of the U.S. Centers for Disease Control and Prevention or International Medical Corps or any institutions that the authors are affiliated with.

References

    1. Christie A., Brooks J.T., Hicks L.A., Sauber-Schatz E.K., Yoder J.S., Honein M.A. Guidance for implementing COVID-19 prevention strategies in the context of varying community transmission levels and vaccination coverage. [(accessed on 21 September 2022)];Morb. Mortal. Wkly. Rep. 2021 70:1044. doi: 10.15585/mmwr.mm7030e2. Available online: https://pmc/articles/PMC8323553/ - DOI - PMC - PubMed
    1. Sharma K., Koirala A., Nicolopoulos K., Chiu C., Wood N., Britton P.N. Vaccines for COVID-19: Where do we stand in 2021? Paediatr. Respir. Rev. 2021;39:22–31. doi: 10.1016/j.prrv.2021.07.001. - DOI - PMC - PubMed
    1. COVID-19 Vaccination in the WHO African Region—10 November 2022|WHO|Regional Office for Africa. [(accessed on 27 November 2022)]. Available online: https://www.afro.who.int/publications/covid-19-vaccination-who-african-r....
    1. Msellati P., Sow K., Desclaux A., Cottrell G., Diallo M., Le Hesran J.-Y., Harczi G., Alfa D.A., Touré A., Manigart O. Reconsidering the COVID-19 vaccine strategy in West and Central Africa. Lancet. 2022;400:1304. doi: 10.1016/S0140-6736(22)01896-7. - DOI - PMC - PubMed
    1. Nachega J.B., A Sam-Agudu N., Masekela R., van der Zalm M.M., Nsanzimana S., Condo J., Ntoumi F., Rabie H., Kruger M., Wiysonge C.S., et al. Addressing challenges to rolling out COVID-19 vaccines in African countries. [(accessed on 27 November 2022)];Lancet Glob. Health. 2021 9:e746–e748. doi: 10.1016/S2214-109X(21)00097-8. Available online: http://www.thelancet.com/article/S2214109X21000978/fulltext. - DOI - PMC - PubMed

LinkOut - more resources